C-CDA Online: A navigation website for C-CDA 2.1

This navigation tool is generated from the published PDF of the Consolidated Clinical Document Architecture (C-CDA) 2.1 (2.1.0.7, September 2022) and the C-CDA 2.1 Companion Guide (4.1.1, June 2023). For the latest information on C-CDA, or to access the Supplemental Implementation Guides, please refer to the HL7 C-CDA Page which remains the definitive source for the standards. CDA and C-CDA are copyright property of Health Level Seven (HL7) and subject to the terms of HL7's IP policy.


HL7 encourages users to sign up for an account, which is free!

Please sign up if you do not have an account. C-CDA Online Navigator last updated: August 2023.

Allergies and Intolerances Section (entries required) (V3) [section, 2.16.840.1.113883.10.20.22.2.6.1, release 2015-08-01, open] view pdf view prototype


Description:

This section lists and describes any medication allergies, adverse reactions, idiosyncratic reactions, anaphylaxis/anaphylactoid reactions to food items, and metabolic variations or adverse reactions/allergies to other substances (such as latex, iodine, tape adhesives). At a minimum, it should list currently active and any relevant historical allergies and adverse reactions.

Contained By: Contains:
Consultation Note (V3)
Continuity of Care Document (CCD) (V3)
Transfer Summary (V2)
Referral Note (V2)
Allergy Concern Act (V3)

Conformance Statements:

HL7 Code Systems are available here. HL7 Value Sets are available here. Links to Value Set Authority Center (VSAC) are shown as hyperlinks and require UMLS login

Guide Examples:


CDA Search Examples



To log an issue on C-CDA Standard, go to HL7 JIRA Tracker To report an issue with this webpage (but not underlying standard) please log in C-CDA Search Github Repository